Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1426 AL 1440

[Non-motor symptoms in Parkinson's disease patients]

Sad AB, Breglia R, Buonanotte CF.

Rev Fac Cien Med Univ Nac Cordoba. 2016;73(2):98-106.

Association between monoamine oxidase B A644G polymorphism and Parkinson's disease risk: a meta-analysis in the Chinese population

Liu JJ, Wang W, Meng M, Liang CS, Zhang JW.

Genet Mol Res. 2016 Jul 14;15(2). doi: 10.4238/gmr.15028349.

Motor symptoms in Parkinson's disease: A unified framework

Moustafa AA, Chakravarthy S, Phillips JR, Gupta A, Keri S, Polner B, Frank MJ, Jahanshahi M.

Neurosci Biobehav Rev. 2016 Sep;68:727-740. doi: 10.1016/j.neubiorev.2016.07.010. Epub 2016 Jul 12.

Fluctuating off-period hemidystonia with Pisa syndrome in advanced Parkinson's disease

Meloni M, Cannas A, Mascia MM, Solla P, Floris G, Di Stefano F, Marrosu F.

J Neurol Sci. 2016 Aug 15;367:138-9. doi: 10.1016/j.jns.2016.06.010. Epub 2016 Jun 5.

Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS)

Santangelo G, Falco F, D'Iorio A, Cuoco S, Raimo S, Amboni M, Pellecchia MT, Longo K, Vitale C, Barone P.

J Neurol Sci. 2016 Aug 15;367:158-61. doi: 10.1016/j.jns.2016.06.008. Epub 2016 Jun 4.

Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study

Tosukhowong P, Boonla C, Dissayabutra T, Kaewwilai L, Muensri S, Chotipanich C, Joutsa J, Rinne J, Bhidayasiri R.

J Neurol Sci. 2016 Aug 15;367:162-70. doi: 10.1016/j.jns.2016.05.056. Epub 2016 May 31.

White matter changes and the development of motor phenotypes in de novo Parkinson's Disease

Moccia M, Tedeschi E, Ugga L, Erro R, Picillo M, Caranci F, Barone P, Brunetti A.

J Neurol Sci. 2016 Aug 15;367:215-9. doi: 10.1016/j.jns.2016.06.015. Epub 2016 Jun 8.

Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis

Antonini A, Chaudhuri KR, Boroojerdi B, Asgharnejad M, Bauer L, Grieger F, Weintraub D.

Eur J Neurol. 2016 Oct;23(10):1556-65. doi: 10.1111/ene.13078. Epub 2016 Jul 18.

Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease

Elsner B, Kugler J, Pohl M, Mehrholz J.

Cochrane Database Syst Rev. 2016 Jul 18;7(7):CD010916. doi: 10.1002/14651858.CD010916.pub2.

Tachyarrhythmia in Wolff-Parkinson-White Syndrome

Kesler K, Lahham S.

West J Emerg Med. 2016 Jul;17(4):469-70. doi: 10.5811/westjem.2016.4.30323. Epub 2016 Jun 16.

Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease

Hauser RA, Olanow CW, Dzyngel B, Bilbault T, Shill H, Isaacson S, Dubow J, Agro A.

Mov Disord. 2016 Sep;31(9):1366-72. doi: 10.1002/mds.26697. Epub 2016 Jul 19.

Concurrent transcranial direct current stimulation and progressive resistance training in Parkinson's disease: study protocol for a randomised controlled trial

Hendy AM, Tillman A, Rantalainen T, Muthalib M, Johnson L, Kidgell DJ, Wundersitz D, Enticott PG, Teo WP.

Trials. 2016 Jul 19;17(1):326. doi: 10.1186/s13063-016-1461-7.

Unmasking levodopa resistance in Parkinson's disease

Nonnekes J, Timmer MH, de Vries NM, Rascol O, Helmich RC, Bloem BR.

Mov Disord. 2016 Nov;31(11):1602-1609. doi: 10.1002/mds.26712. Epub 2016 Jul 19.

New methods for the assessment of Parkinson's disease (2005 to 2015): A systematic review

Sánchez-Ferro Á, Elshehabi M, Godinho C, Salkovic D, Hobert MA, Domingos J, van Uem JM, Ferreira JJ, Maetzler W.

Mov Disord. 2016 Sep;31(9):1283-92. doi: 10.1002/mds.26723. Epub 2016 Jul 19.

The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

Martínez-Fernández R, Schmitt E, Martinez-Martin P, Krack P.

Mov Disord. 2016 Aug;31(8):1080-94. doi: 10.1002/mds.26731. Epub 2016 Jul 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias